DOCSLIB.ORG

Drug Enforcement Administration's International Operations

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Drug Enforcement Administration's International Operations REDACTED – PUBLIC VERSION THE DRUG ENFORCEMENT ADMINISTRATION’S INTERNATIONAL OPERATIONS U.S. DEPARTMENT OF JUSTICE OFFICE OF THE INSPECTOR GENERAL AUDIT DIVISION AUDIT REPORT 07-19 FEBRUARY 2007 REDACTED – PUBLIC VERSION REDACTED – PUBLIC VERSION THE DRUG ENFORCEMENT ADMINISTRATION’S INTERNATIONAL OPERATIONS* EXECUTIVE SUMMARY The Drug Enforcement Administration (DEA) is the primary federal agency responsible for investigating illicit drug trafficking organizations operating within the United States. The ultimate goal of the DEA’s efforts is to significantly disrupt drug trafficking operations and to dismantle the criminal organizations entirely, while ultimately bringing their leaders to prosecution, either in the United States or through another country’s judicial system. In order to combat the highest priority drug trafficking organizations, the DEA must extend its operations to other countries where major drug traffickers live and preside over illegal operations. As a result, the DEA has 751 employees in 59 other countries who work with foreign law enforcement agencies, as well as with other U.S. agencies operating in the international arena, to accomplish its mission.1 To support its personnel and operations abroad, in fiscal year (FY) 2006 the DEA had a budget of $312 million for its international operations. The Department of Justice (DOJ), Office of the Inspector General (OIG) conducted this audit of the DEA’s international operations. The objectives of the audit were to: (1) review the DEA’s foreign office performance, including its efforts to track operational activity and its internal mechanisms for evaluating the performance of its foreign operations; (2) examine the DEA’s involvement and management of international investigative activity; (3) assess the DEA’s relationships with its law enforcement counterparts abroad, including its liaison associations and the exchange of information; (4) analyze the DEA’s processes and controls over foreign administrative functions, including those related to security, firearms, property management, and fiscal matters; and (5) review the training provided or coordinated by the DEA to its foreign counterparts and DEA personnel stationed abroad. * The full version of this report includes information that the DEA considered to be law enforcement sensitive and therefore could not be publicly released. To create this public version of the report, the OIG redacted (deleted) the portions of the full report that were considered sensitive by the DEA and indicated where those redactions were made. 1 The 751 employee figure represents the number of allocated positions as of May 2006. REDACTED – PUBLIC VERSION REDACTED – PUBLIC VERSION Our review included work at DEA headquarters components and at 10 DEA foreign offices in 5 countries: Colombia, Italy, Mexico, Thailand, and Turkey. Our methodology involved selecting locations that would provide a broad overall perspective of DEA’s international operations, including diverse geographic location, jurisdiction, operational activity, and personnel composition. During our field visits abroad, we interviewed DEA personnel as well as representatives from U.S. and foreign agencies who work with the DEA internationally. We also reviewed pertinent DEA documentation and analyzed data from DEA databases. Appendix I contains additional details related to our audit objectives, scope, and methodology. Background In 2002, DOJ created a register of the United State’s most significant illicit drug trafficking targets called the Consolidated Priority Organization Target (CPOT) list. According to DOJ officials, this list is updated at least annually based on a collection of intelligence from various agencies, and since its inception the CPOT list has contained a total of 80 targets, none of whom resided in the United States. As of June 2006, the list included 46 targets. Since the current DEA Administrator took office in 2003, the DEA has increased its number of foreign offices, bolstered its international funding, and augmented the number of personnel assigned to combat foreign drug trafficking and organizations. Since 1997, the DEA has increased its foreign allocated personnel by 195 positions, from 556 to 751. The DEA’s foreign budget has increased from $201 million in FY 2000 to $312 million in FY 2006. Moreover, the percentage growth in the DEA’s international operations budget has outpaced that of its overall budget, as shown in the following graph. DEA BUDGET PERCENTAGE GROWTH SINCE FY 2000 TOTAL BUDGET vs INTERNATIONAL BUDGET Total Budget International Budget 80% 70% 60% 50% 40% 30% 20% 10% 0% -10% 2000 2001 2002 2003 2004 2005 2006 2007 (projected) Source: OIG analysis of Drug Enforcement Administration budget figures ii REDACTED – PUBLIC VERSION REDACTED – PUBLIC VERSION According to the DEA, it only opens offices in countries that are in some way tied to the flow of illegal drugs into the United States. This includes countries that are a source of drugs or precursor chemicals, countries where significant money laundering occurs, or countries that are linked to drug trafficking organizations that threaten the United States.2 The host country, the U.S. Chief of Mission, and Congress must authorize the DEA to open a new foreign office. As a sovereign state, any host country may withdraw this permission at any time. In addition, the DEA’s legal operating ability in other countries is much different than in its domestic offices because DEA agents stationed overseas do not have law enforcement jurisdiction. DEA’s authorities differ from country to country depending on host-country laws, agreements between governments, international treaties, and local policies issued to U.S. agencies by the U.S. Ambassador. Despite different working environments in its foreign offices, the DEA maintains five principal objectives for working with foreign counterpart agencies: (1) participate in bilateral investigations, (2) cultivate and maintain quality liaison relations, (3) promote and contribute to foreign institution building, (4) support intelligence gathering and sharing efforts, and (5) provide training opportunities. In 2007, the DEA intends to open new offices in Dubai, United Arab Emirates, and Dushanbe, Tajikistan. In addition, the DEA has received congressional approval to open an office in Bishkek, Kyrgyzstan. The DEA is also working with the government of Mexico to obtain its authorization for the opening of congressionally approved offices in Matamoros, Nogales, and Nuevo Laredo, Mexico. The placement of DEA’s international offices as of June 2006 is shown on the following map. 2 Precursor chemicals are materials used in the manufacture of a controlled substance. iii REDACTED – PUBLIC VERSION REDACTED – PUBLIC VERSION DEA Foreign Offices (as of June 2006)3 Source: Drug Enforcement Administration’s Office of International Programs 3 The office in Warsaw, Poland, opened in 2006. The future offices identified in Mexico are pending approval from the government of Mexico. iv REDACTED – PUBLIC VERSION REDACTED – PUBLIC VERSION In foreign countries, DEA offices are part of the U.S. Embassy mission and may be housed within or outside the Embassy or the Consulate. The primary DEA office in another country is referred to as the DEA Country Office and secondary offices are called Resident Offices. A typical DEA foreign office is staffed by Special Agents, Intelligence Research Specialists, administrative support personnel, and foreign national hires, also known as foreign service nationals (FSNs).4 The senior DEA position in each Country Office is the DEA Country Attaché. In addition to reporting to DEA management, the DEA Country Attaché must also report to the U.S. Ambassador on DEA matters and activities within the host country. The DEA has divided its foreign offices into seven regions that were established based upon the trafficking trends and environments of the various countries. These regions are managed by Regional Directors who are located within certain DEA foreign offices. A Regional Director has overall responsibility for the activities of DEA Country Offices and Resident Offices in multiple countries. For example, the DEA Regional Director for the Andean Region is located in Bogotá, Colombia, and is responsible for countries predominantly located along the northern portion of the Andes mountain range in South America, including Colombia, Peru, Ecuador, and Venezuela. The seven regions and the location of the Regional Director’s office are shown below. DEA Foreign Region Regional Director Location Andean Bogotá, Colombia European Rome, Italy Mexico/Central America Mexico City, Mexico Far East Bangkok, Thailand Middle East Ankara, Turkey Southern Cone La Paz, Bolivia Caribbean San Juan, Puerto Rico5 Performance Management In this audit, we reviewed DEA data related to the success of its foreign offices’ highest priority cases, which are labeled Priority Target 4 Foreign service nationals are non-U.S. citizens who enter into employment contracts with U.S. government offices abroad, including DEA foreign offices. 5 The Caribbean Region is managed by the Special Agent in Charge of the DEA’s San Juan Division, which the DEA considers a domestic office with oversight responsibility for DEA domestic and foreign offices in the Caribbean. This Special Agent in Charge effectively performs the function of a Regional Director for the DEA’s Caribbean Region. v REDACTED – PUBLIC VERSION REDACTED – PUBLIC VERSION Organizations (PTO).6 According to this data, as
Load more

Recommended publications
  • 1. CAMBODIA 1.1 General Situation 1.1.1 Drug Use There Are No
    COUNCIL OF Brussels, 15 April 2014 THE EUROPEAN UNION (OR. en) 8990/14 CORDROGUE 26 ASIE 22 NOTE From: Japanese Regional Chair of the Dublin Group To: Dublin Group No. prev. doc.: 14715/13 Subject: Regional Report on South East Asia and China 1. CAMBODIA 1.1 General situation 1.1.1 Drug use There are no consistent statistics as to the exact number of people who use drugs in Cambodia. However the general consensus among the Royal Government of Cambodia and international agencies is that there are currently between 12,000 and 28,000 people who use drugs. Methamphetamine pills are the most widely used drug in Cambodia, although crystalline methamphetamine is becoming more widely available, with use on the rise, particularly in Phnom Penh and among unemployed youth. Whereas illicit drug use was previously concentrated primarily in urban settings, in recent years it has been expanding into rural areas, in particular in the provinces adjacent to Lao PDR and Thailand (INCSR Cambodia 2012). Drug use among women and within prisons appears to be on the rise (UNODC 2013). 8990/14 JV/fm 1 DG D 2C EN Table 1. Rank of primary drugs of concern in Cambodia, 2008-2012 Drug type 2008 2009 2010** 2011*** 2012**** Methamphetamine pills ● 2* 1 2 2 Crystalline methamphetamine ● 1* 2 1 1 Ecstasy ● ● ● 6 ● Cannabis ● ● 4 4 4 Heroin ● ● 3 5 ● Inhalants ● ● ● 3 3 Opium ● ● ● ● ● ● = Not reported Source(s): *NACD 2010a. **2010 rankings based on DAINAP data and Cambodia country reports. ***NACD 2012b. ****2012 rankings are based on data provided by the National Authority for Combating Drugs.
    [Show full text]
  • Methamphetamine Use: Lessons Learned
    The author(s) shown below used Federal funds provided by the U.S. Department of Justice and prepared the following final report: Document Title: Methamphetamine Use: Lessons Learned Author(s): Dana Hunt, Ph.D.; Sarah Kuck; Linda Truitt, Ph.D. Document No.: 209730 Date Received: February 2006 Award Number: 99-C-008 This report has not been published by the U.S. Department of Justice. To provide better customer service, NCJRS has made this Federally- funded grant final report available electronically in addition to traditional paper copies. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. ANALYTIC SUPPORT PROGRAM CONTRACT TASK REQUIREMENT T-043: Methamphetamine Use: Lessons Learned Contract No. 99-C-008 Cambridge, MA Lexington, MA Hadley, MA Bethesda, MD Chicago, IL January 31, 2006 Prepared for Raymond C. German Contracting Officer Christine Crossland Senior Social Science Analyst National Institute of Justice Office of Justice Programs Acquisition Management Division 810 Seventh Street, SW Washington, D.C. 20001 Prepared by Dana Hunt, Ph.D. Sarah Kuck Abt Associates Inc. Linda Truitt, Ph.D. 55 Wheeler Street Cambridge, MA 02138 Contents Executive Summary...............................................................................................................iii History of Methamphetamine Use .................................................................................iii Trends.............................................................................................................................iii
    [Show full text]
  • National Drug Threat Assessment 2002
    National Drug Intelligence Center U.S. Department of Justice U.S. Department of Justice National Drug Intelligence Center Product No. 2002-Q0317-001 December 2001 National Drug Threat Assessment 2002 National Drug Intelligence Center 319 Washington Street, 5th Floor Johnstown, PA 15901-1622 (814) 532-4601 National Drug Threat Assessment 2002 From the Director: I am pleased to present the National Drug Threat Assessment 2002, the culmination of dedicated work by the National Drug Intelligence Center in partnership with federal, state, and local agencies and organizations. In accordance with the provisions of the General Counterdrug Intelligence Plan, the National Drug Threat Assessment integrates foreign and domestic counterdrug intelligence and information on domestic drug consumption trends in a single report. This report is a comprehensive assessment of the threat posed to our society by illicit drugs. It integrates the most recently available reporting from national-level law enforcement, intelligence, and health and human service agencies including the Drug Enforcement Administration, Federal Bureau of Investigation, U.S. Coast Guard, U.S. Customs Service, El Paso Intelligence Center, Financial Crimes Enforcement Network, Crime and Narcotics Center, National Institute on Drug Abuse, Substance Abuse and Mental Health Services Administration, and National Institute of Justice. It incorporates data from current national drug abuse indicators—Arrestee Drug Abuse Monitoring Program, Drug Abuse Warning Network, Monitoring the Future Study, National Household Survey on Drug Abuse, Parents’ Resource Institute on Drug Education Survey, and Treatment Episode Data Set—to accurately and reliably depict the current domestic drug abuse situation. The National Drug Threat Assessment draws on information provided by nearly 2,600 state and local law enforcement agencies throughout the country to document the current threat and emerging trends in drug trafficking and related criminal activity in the United States.
    [Show full text]
  • (ATS) Production and Trafficking in Southeast Asia Countries
    Risalah HUKUM Fakultas Hukum Unmul, Juni 2010, Hal. 53 - 62 Vol. 6, No. 1 ISSN 021-969X Amphetamines Type Stimulant (ATS) Production and Trafficking In Southeast Asia Countries Milda Istiqomah Fakultas Hukum Universitas Brawijaya Jl.MT.Haryono Nomor 169 Malang 65145 e-mail:[email protected] ABSTRACT This article addresses the pattern of Amphetamines Type Stimulants (ATS) production and trafficking in Southeast Asia countries. The objective of this article is to investigate organizational form and trafficking network of ATS within the region. Indonesia, Myanmar, and Cambodia will be used as analyzing case of the largest amphetamine producing and trafficking centre in the territory. The poverty, geo-strategic location, unstable sociopolitical situation and systemic corruption in law enforcement agencies are identified as the root of the emergence of multifaceted and transnational drugs trafficking in Southeast Asia. This article also provides suggestion on how to circumvent the impediments faced by the governments. Key words: amphetamines type stimulants and trafficking Introduction countries are responsible for contributing the Southeast Asia countries are facing a illicit drugs trafficking within the world. Several serious threat of their security from drugs countries within this region are posing as trafficking recently. The golden triangle producing, supplying and transiting point of countries consisting of Burma, Thailand and illicit drugs. Laos are pointed as the world’s second largest Gary Reid et al address a report of opium producer and supplier in the Asia Pacific drug production, trafficking and trade in Asia region. Amphetamines productions are also and Pacific Island countries. 1 They estimate found throughout most of the Southeast Asia that Myanmar is the largest producer of opium region, in particular Indonesia, Myanmar and around “370 metric tones” in the Asia region, Cambodia.
    [Show full text]
  • Methamphetamine Use Among Thai Women: a Qualitative
    METHAMPHETAMINE USE AMONG THAI WOMEN: A QUALITATIVE STUDY AT THANYARAK INSTITUTE By Sarun Gorsanan A Thesis Submitted in Partial Fulfillment of the Requirements for the Degree DOCTOR OF PHILOSOPHY Program of Social and Administrative Pharmacy Graduate School SILPAKORN UNIVERSITY 2006 การใชเมทแอมเฟตามีนในสตรีไทย : การวิจัยเชิงคุณภาพในสถาบันธัญญารักษ โดย นายศรัณย กอสนาน วิทยานิพนธน ี้เปนสวนหนงของการศึ่ ึกษาตามหลกสั ูตรปริญญาเภสัชศาสตรดุษฎีบัณฑิต สาขาวิชาเภสชศาสตรั สังคมและการบริหาร บัณฑิตวทยาลิ ัย มหาวิทยาลัยศิลปากร ปการศึกษา 2549 ลิขสิทธิ์ของบณฑั ิตวิทยาลยั มหาวิทยาลยศั ิลปากร The graduate school, Silpakorn University accepted thesis entitled “METHAMPHETAMINE USE AMONG THAI WOMEN: A QUALITATIVE STUDY AT THANYARAK INSTITUTE” by Sarun Gorsanan in partial fulfillment of the requirements for the degree of Doctor of Philosophy, Program of Social and Administrative Pharmacy. …………………………………………….. (Assoc.Prof. Sirichai Chinatankul, Ph.D.) Dean of Graduate School ……….../…………/…………… Thesis advisors 1. Pagamas Maitreemit, Ph.D. 2. Assoc.Prof. Chuthamanee Suthisisang, Ph.D. 3. Assoc.Prof. Luechai Sringernyuang, Ph.D. Thesis committee …………………………….. Chairman …………………………….. Member (Assist. Prof. Burin T. Sriwong, Ph.D.) (Prof. Chomchin Chantaraskul, Ph.D.) ……….../…………/…………… ……….../…………/…………… …………………………….. Member …………………………….. Member (Pagamas Maitreemit, Ph.D.) (Assoc.Prof. Chuthamanee Suthisisang, Ph.D.) ……….../…………/…………… ……….../…………/…………… …………………………….. Member (Assoc.Prof. Luechai Sringernyuang, Ph.D.) ……….../…………/…………… 45354901: MAJOR: SOCIAL AND ADMINISTRATIVE
    [Show full text]
  • Myanmar/Burma 1. General Situation 1.1 Opium and Opiates
    Council of the European Union Brussels, 13 April 2015 (OR. en) 7849/15 CORDROGUE 21 ASIE 13 NOTE From: Australian Regional Chair of the Dublin Group To: Delegations No. prev. doc.: 14832/14 CORDROGUE 81 ASIE 66 Subject: Regional Report on South East Asia and China Myanmar/Burma 1. General Situation 1.1 Opium and opiates Myanmar is considered to be the second largest producer of opium in the world, behind Afghanistan. East Asia illicit opiate industry value is estimated at $16.3 billion per year, the majority of which is driven from Myanmar opium/heroin. In 1999 the Myanmar Government and local authorities engaged in a 15-year plan to eliminate opium poppy cultivation by 2014. This Plan has now been extended a further five years and will conclude in 2019. Until 2006 there was a considerable decrease in the total area under opium poppy cultivation in Myanmar, as a result of efforts to eradicate opium poppy cultivation as well as the imposition by local authorities of an opium ban in the Wa region in June 2005 and in the Kokang Special Region in 2003. 7849/15 JV/np 1 DG D 2C EN However, illicit opium poppy cultivation has since increased although it is still well below the levels reached in the 1990s. After reaching a minimum level in 2006, opium cultivation began to gradually increase again in 2007. According to the UNODC Opium Poppy Survey report1 on Myanmar, poppy cultivation in Myanmar rose 13% from the previous year to 57,800 hectares, more than doubling since 2006.
    [Show full text]
  • ATS Problems in Southeast Asia
    Amphetamine Type Stimulants problems Especially in South-East Asia • Global and Asian Trends • Short and long-term effects • Treatment of Stimulant Use disorder • Methamphetamine treatment system in Thailand • Dr. Apinun Aramrattana • Southeast Asia HIV Addiction Technology Transfer Center • Dept. of Family Medicine, Faculty of Medicine, Chiang Mai University, Thailand Expanding market: Amphetamine-type stimulants (ATS) ATS seized worldwide • Total ATS seizures: highest ever • Amphetamine and methamphetamine constitute considerable share of burden of disease, rank second only after opioids • Users of amphetamines increased, reaching 37 million globally • Methamphetamine seizures up, East and South-East Asia overtaking North America • “Ecstasy” seizures stable but greater variety of products on the market Rapid methamphetamine pill epidemics in Thailand DRUG TREATMENT STATISTICS 0.4 0.6 1.1 1 1.7 2.6 NUMBER 100% 10.6 12.8 7.7 5.3 19.3 16.5 13.8 34.1 80% 5.3 53.7 57.4 60% 60.3 6.3 Thai Act 1996:83.4 84.9 40% 73.7 78.2 76 71.1Amp./meth.72.5 moved to Sch.I 5.7 6.6 6 47.8 20% 32.1 24.1 19.6 0% 1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 Heroin Opium Ganja Inhalant Alcohol ATS Others Source: Dept. of Medical Services, MOPH and Institute of Health Research,C U., ONCB V.Poshyachinda - Methamphetamine 15-20 % + Caffeine 50-65% Household Survey Trends: Ever users: 2001-2016 War on Drugs since 2003 Estimated Numbers ( x 1,000) Source: ACSAN, ONCB, 2012 Methamphetamine tablets(Ya Ba), Marihuana, and Kratom are the most common drugs used with Ice epidemics emerging.
    [Show full text]
  • The United Wa State Army and Burma's Peace Process
    The United Wa State Army and Burma’s Peace Process By Bertil Lintner NO. 147 | APRIL 2019 Making Peace Possible NO. 147 | APRIL 2019 ABOUT THE REPORT Supported by USIP’s Asia Center to provide policymakers and the general public with a better understanding of Burma’s ethnic conflicts, this report examines the role of PEACE PROCESSES both the United Wa State Army and China in Burma’s peace process and suggests ways forward to break the present stalemate. ABOUT THE AUTHOR Bertil Lintner has covered Burma’s civil war and related issues such as narcotics trafficking for more than thirty-five years. Burma correspondent for the Far Eastern Economic Review from 1982 to 2004, he now writes for Asia Times and is the author of several books about Burma’s civil war and ethnic strife. Cover photo: United Wa State Army soldiers march during a media display in Panghsang, in the Wa Self-Administered Division of Shan State, Burma. (Photo by Soe Zeya Tun/Reuters) The views expressed in this report are those of the author alone. They do not necessarily reflect the views of the United States Institute of Peace. An online edition of this and related reports can be found on our website (www.usip.org), together with additional information on the subject. © 2019 by the United States Institute of Peace United States Institute of Peace 2301 Constitution Avenue NW Washington, DC 20037 Phone: 202.457.1700 Fax: 202.429.6063 E-mail: [email protected] Web: www.usip.org Peaceworks No. 147. First published 2019. ISBN: 978-1-60127-765-7 Making Peace Possible Contents 3 Introduction 4 Who Are the Wa? 6 Communism 10 Drug Trafficking 13 The UWSP, UWSA, and Their Allies 16 The UWSP and China’s Role in the Peace Process 22 Conclusion and Policy Recommendations USIP.ORG 1 Summary The United Wa State Army (UWSA), with its twenty-odd thousand men in arms, is the largest of Burma’s ethnic armed organizations (EAOs).
    [Show full text]
  • Submission to the Committee's Inquiry Into Amphetamine and Other Synthetic Drugs and to Subsequent Telephone Conversations Between Your Office and Mr Bush
    nd Friendsfor DrugLaw Reform(ACT) Inc. tragedythat arisesfrom illicit drug use POBox 36,HIGGINS ACT 2615 Telephone (02)62542961 Email [email protected]. au Web www.ffdlr.org.au 17 March, 2006 Dear Mr Curtis rNQUrRy rNTO AlvtPHETAlvtrNEAlilD OTHER SYNTHETIC DRUGS I refer to your l-etter dated 8 December inviting Famil-ies and Friends for Drug Law Reform to provide a submission to the Committee's inquiry into amphetamine and other synthetic drugs and to subsequent telephone conversations between your office and Mr Bush. We are grateful for the generous extensions that your of f j-ce has allowed us. Please find attached a submission that we have prepared. You will- see that reference is made in it to a number of submissions of Families and Friends for Drug Law Reform to varj-ous parliamentary inquiries. In particular our present submission refers to the two submissions we made last year for the Commi-ttee's review of the AustraJ-ian Crime Commission Act 2002. We woul-d be grateful if the Committee would consi-der the present submission in coniunction with those. We woul-d also be grateful for the opportunity to appear before the Committee to expand on aspects of the submission. Vice-President Mr Jonathan Curtis Committee Secretary Parliamentary Joint Committee on the Australian Crime Commission Parl-i-ament House CANBERRA ACT 2600 Associatedwith the AusrnalrAN Dnuc L^q,wRnronu FouxunTroN Families and Friends for Drug Law Reform (ACT) Inc. committed to preventing tragedy that arises from illicit drug use PO Box 36, HIGGINS ACT 2615 Telephone (02) 6254 2961 Email [email protected] Web www.ffdlr.org.au SUBMISSION OF FAMILIES AND FRIENDS FOR DRUG LAW REFORM TO THE INQUIRY BY THE PARLIAMENTARY JOINT COMMITTEE ON THE AUSTRALIAN CRIME COMMISSION INTO AMPHETAMINES AND OTHER SYNTHETIC DRUGS TABLE OF CONTENTS TABLE OF FIGURES __________________________________________________ iii EXECUTIVE SUMMARY________________________________________________ iv I.
    [Show full text]
  • Methamphetamine Continues to Dominate Synthetic Drug Markets ENES
    GLOBAL 20 S MART September UPDATE VOLUME VOLUME Methamphetamine continues to dominate synthetic drug markets ENES Research 2018 GLOBAL SMART UPDATE About the SMART Update Content Synthetic drugs constitute one of the most significant Methamphetamine continues to dominate drug problems worldwide. After cannabis, amphet- synthetic drug markets 3 amine-type stimulants (ATS) are the second most Introduction 3 widely used drugs across the globe, with use levels often exceeding those of heroin and/or cocaine. Along Are the threats of methamphetamine with ATS, the continued growth of the new psychoac- underestimated? 3 tive substances (NPS) market over the last years has Analysing methamphetamine seizures: become a policy challenge and a major international a case study of China and Myanmar 5 concern. A growing interplay between these new drugs Prices along the methamphetamine and traditional illicit drug markets is being observed. trafficking chain 6 By December 2017, the emergence of NPS had been reported by 111 countries and territories. Trends on the The two hubs for methamphetamine: East and synthetic drug market evolve quickly each year. South-East Asia and North America 6 The UNODC Global Synthetics Monitoring: Analyses, Trends in methamphetamine manufacture 7 Reporting and Trends (SMART) Programme enhances Is methamphetamine use growing? 7 the capacity of Member States in priority regions to Diversification of the methamphetamine market 9 generate, manage, analyse, report and use synthetic drug information to design effective policy
    [Show full text]
  • Street Names of Ecstasy-Country Specific
    STREET NAMES OF ECSTASY-COUNTRY SPECIFIC Crystalline Methamphetamine MDMA Precursors used Methamphetamine Tablets Australia Ice, crystal meth, Meth, meth tabs Ecstasy, E, Ephedrine/Pseudo- crystal, shabu pingers ephedrine/ ephedra/Phenyl Acetic Acid Cambodia Ice, ya ba chakk, ya ya ba, ya ma, ma thnam krovee --do-- ma kbai (shake- chakk, ma chakk head drug); (chakk = injectable); some young also ya ba, ya ma, ma people say “ecstasy” China bingdu (ice) bingdu pian, ma yao tou ubin --do-- ku (head-shaking pill) Indonesia shabu XTC --do-- Lao PDR ya ba, ya ma ya-E --do-- Japan shabu, “S”, ice, speed; “X”, ecstasy --do-- anpon (particular to Kyushu region); philopoon (liquid methamphetamine) Malaysia Crystal, syabu, ice Meth Ecstasy --do-- Myanmar ya ma, seik kwya Seik kwya say --do-- say, myin say (head-shaking pill) New Zealand "P", crystal, ice Meth tabs Ecstasy --do-- Philippines shabu, bato, sha, XTC, love drug --do-- siopao Thailand ice ya ba ya-E, ya-Love --do-- Viet Nam shaking pill --do-- OTHER STREET NAMES Adam Ecstasy, Methylenedioxymethamphetamine (MDMA) Batmans Methylenedioxymethamphetamine (MDMA) B-Bombs Amphetamines; MDMA A capsule containing drugs; MDMA Bean (methylenedioxymethamphetamine) Bens Amphetamine; MDMA Bibs MDMA Blue Kisses, Blue Methylenedioxymethamphetamine (MDMA) Lips Bumping up MDMA combined with powder cocaine Candyflipping The combined use of ecstasy and LSD Caps Heroin; psilocybin/psilocin; crack Charity Methylenedioxymethamphetamine Chalk MDMA Chemical Ice MDMA Cloud nine Crack cocaine; MDMA Club Drug MDMA
    [Show full text]
  • DETENTION AS TREATMENT Detention of Methamphetamine Users in Cambodia, Laos, and Thailand
    DETENTION AS TREATMENT Detention of Methamphetamine Users in Cambodia, Laos, and Thailand DETENTION AS TREATMENT Detention of Methamphetamine Users in Cambodia, Laos, and Thailand March 2010 International Harm Reduction Development Program Copyright © 2010 Open Society Institute. All rights reserved. Writing: Nick Thomson Editing: Roxanne Saucier and Daniel Wolfe Copy Editing: Paul Silva and Thomas Bane Layout: Judit Kovács l Createch Ltd. For more information, contact: International Harm Reduction Development Program OSI Public Health Program www.soros.org/health Telephone 1 212 548 0600 Email [email protected] Acknowledgments This report would not have been possible with out the assistance and support of many people working in the Southeast Asian region and indeed outside of the region. I would like thank the people who have shared their experiences of compulsory detention. I would like to thank my colleagues from the field who were instrumental in collecting and analyzing interviews, including Sara Bradford in Cambodia, Khun Non in Thailand and Mr. Gai in Laos. Many individuals working within particular government departments in Thailand, Laos and Cambodia provided information and shared their thoughts on this issue and I am grateful for their assistance. I was given much informal support from various people within UN agencies in the region, particularly WHO in Cambodia. This work would not have been possible without the help of Patrick Duigan and the journalistic and investigative talents of Tom Fawthrop. Professor Chris Beyer from the Center for Public Health and Human Rights at Johns Hopkins School of Public Health provided significant technical advice and also reviewed several drafts as did Katie Sutcliffe from the Department of Epidemiology.
    [Show full text]